Canada markets closed

Nuvectis Pharma, Inc. (NVCT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
8.14+1.38 (+20.41%)
At close: 04:00PM EDT
7.70 -0.44 (-5.41%)
After hours: 06:46PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 149.54M
Enterprise Value 130.41M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)12.26
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -5.70

Trading Information

Stock Price History

Beta (5Y Monthly) 0.27
52-Week Change 3-55.23%
S&P500 52-Week Change 322.38%
52 Week High 318.65
52 Week Low 35.92
50-Day Moving Average 38.29
200-Day Moving Average 39.97

Share Statistics

Avg Vol (3 month) 397.19k
Avg Vol (10 day) 372.81k
Shares Outstanding 518.37M
Implied Shares Outstanding 618.37M
Float 86.42M
% Held by Insiders 155.33%
% Held by Institutions 116.53%
Shares Short (Apr 15, 2024) 4822.55k
Short Ratio (Apr 15, 2024) 49.59
Short % of Float (Apr 15, 2024) 48.93%
Short % of Shares Outstanding (Apr 15, 2024) 44.63%
Shares Short (prior month Mar 15, 2024) 4766.09k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-69.14%
Return on Equity (ttm)-168.51%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-22.26M
Diluted EPS (ttm)-1.43
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)19.13M
Total Cash Per Share (mrq)1.08
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.75
Book Value Per Share (mrq)0.70

Cash Flow Statement

Operating Cash Flow (ttm)-15.95M
Levered Free Cash Flow (ttm)-7.83M